You are here

News

Comment

Discuss

Coverage of the latest news and updates from ongoing clinical trials from various sources.

February 21, 2012

It then alleges that Morales falsely represented to the public that he was a physician licensed to practice medicine in the United States and provided medical advice to individuals regarding the benefits of stem cell treatments.

February 21, 2012

The Kyoto team, led by Mitinori Saitou, used a three-step process. First they developed a very specific cocktail of three factors that were able to differentiate the stem cells into epiblast-like cells, a cell type that appears very transiently around Day 8 of embryo formation in mice.

February 21, 2012

When the researchers tracked the transplanted cells they found they migrated to a brain region known to support the growth of neurons, where the cells then developed into three types of neural tissue: neurons, astrocytes and oligodendrocytes.

February 21, 2012

To generate the iPSCs, the team followed the standard four-gene reprogramming procedure, but sought to minimize other potential sources of DNA mutations that might have influenced some previously reported results.

February 21, 2012

The findings were also published online in the Journal of the American Medical Association.

February 21, 2012

So far, however, nuclear transfer has not yet been successful in human cells. Many scientists have turned instead to stem cell lines created by reprogramming adult cells (usually skin cells) taken from patients.

February 21, 2012

Thirty-five patients received the cell transplant while 36 had sham surgery. After 12 months, the investigators found no significant difference in the motor scores of the two groups, with both improving approximately 21 percent.

February 21, 2012

Ten days later a second team of Stanford researchers, this time in the lab of Gerald Crabtree, published a Nature online report demonstrating how they had improved on Wernig's method and greatly increased the efficiency of converting skin to neuron.

February 21, 2012

The California Institute of Regenerative Medicine had agreed to lend Geron up to $25 million to pay for the trial, which was designed mainly to test the safety of embryonic stem cells on patients with severe spinal cord injury. Dr.

February 21, 2012

The Moorfields' surgeons will inject between 50,000 and 200,000 cells behind the retina through a fine needle in an outpatient operation expected to take up to an hour. Only patients with advanced Stargardt's will be admitted to the trial.

Pages